The presence of the PD1/PD-L1 axis has been observed in cholangiocarcinoma tumor cells and TILs, indicating the possibility of eliciting immune responses through anti-PD1 or anti-PD-L1 immunotherapy (26). The gene discussed is CD274; the disease is cholangiocarcinoma.